Upper respiratory tract disease, force of infection, and effects on survival of gopher tortoises.

Upper respiratory tract disease (URTD) caused by Mycoplasma agassizii has been hypothesized to contribute to the decline of some wild populations of gopher tortoises (Gopherus polyphemus). However, the force of infection (FOI) and the effect of URTD on survival in free-ranging tortoise populations remain unknown. Using four years (2003-2006) of mark-recapture and epidemiological data collected from 10 populations of gopher tortoises in central Florida, USA, we estimated the FOI (probability per year of a susceptible tortoise becoming infected) and the effect of URTD (i.e., seropositivity to M. agassizii) on apparent survival rates. Sites with high (> or = 25%) seroprevalence had substantially higher FOI (0.22 +/- 0.03; mean +/- SE) than low (< 25%) seroprevalence sites (0.04 +/- 0.01). Our results provide the first quantitative evidence that the rate of transmission of M. agassizii is directly related to the seroprevalence of the population. Seropositive tortoises had higher apparent survival (0.99 +/- 0.0001) than seronegatives (0.88 +/- 0.03), possibly because seropositive tortoises represent individuals that survived the initial infection, developed chronic disease, and experienced lower mortality during the four-year span of our study. However, two lines of evidence suggested possible effects of mycoplasmal URTD on tortoise survival. First, one plausible model suggested that susceptible (seronegative) tortoises in high seroprevalence sites had lower apparent survival rates than did susceptible tortoises in low seroprevalence sites, indicating a possible acute effect of infection. Second, the number of dead tortoise remains detected during annual site surveys increased significantly with increasing site seroprevalence, from approximately 1 to approximately 5 shell remains per 100 individuals. If (as our results suggest) URTD in fact reduces adult survival, it could adversely influence the population dynamics and persistence of this late- maturing, long-lived species.

[1]  M. L. Goff,et al.  THE EPIZOOTIOLOGY AND ECOLOGICAL SIGNIFICANCE OF MALARIA IN HAWAIIAN LAND BIRDS , 1986 .

[2]  Kenneth H. Pollock,et al.  CAPTURE-RECAPTURE STUDIES FOR MULTIPLE STRATA INCLUDING NON-MARKOVIAN TRANSITIONS , 1993 .

[3]  C. Packer,et al.  A canine distemper virus epidemic in Serengeti lions (Panthera leo) , 1996, Nature.

[4]  D. Heisey,et al.  The fitting of general force-of-infection models to wildlife disease prevalence data. , 2006, Ecology.

[5]  K. Burnham,et al.  Program MARK: survival estimation from populations of marked animals , 1999 .

[6]  C. K. Dodd.  Disarticulation of Turtle Shells in North-Central Florida: How Long Does a Shell Remain in the Woods? , 1995 .

[7]  Larry B. Crowder,et al.  Predicting the impact of Turtle Excluder Devices on loggerhead sea turtle populations , 1994 .

[8]  S. Collinge,et al.  Disease ecology: community structure and pathogen dynamics. , 2006 .

[9]  Shelly Lachish,et al.  The impact of disease on the survival and population growth rate of the Tasmanian devil. , 2007, The Journal of animal ecology.

[10]  New focus on wildlife healthTracking and controlling animal disease in the wild may be important to conservation efforts , 1991 .

[11]  R. May,et al.  Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.

[12]  A. Cunningham.  Disease Risks of Wildlife Translocations , 1996 .

[13]  D. Lindenmayer,et al.  The importance of disease in reintroduction programmes , 1993 .

[14]  P. Bonnet,et al.  A mathematical model of the effects of chronic carriers on the within-herd spread of contagious bovine pleuropneumonia in an African mixed crop-livestock system. , 2004, Preventive veterinary medicine.

[15]  C Arrowsmith,et al.  Analysis of aggregation, a worked example: numbers of ticks on red grouse chicks , 2001, Parasitology.

[16]  André A Dhondt,et al.  Spatial spread of an emerging infectious disease: conjunctivitis in House Finches. , 2006, Ecology.

[17]  P. Daszak,et al.  Emerging infectious diseases of wildlife--threats to biodiversity and human health. , 2000, Science.

[18]  Lori D. Wendland,et al.  Distribution and prevalence of upper respiratory tract disease in gopher tortoises in Florida. , 2000 .

[19]  Stephen P. Ellner,et al.  When is it meaningful to estimate an extinction probability , 2000 .

[20]  J. Diemer.  THE ECOLOGY AND MANAGEMENT OF THE GOPHER TORTOISE IN THE SOUTHEASTERN UNITED STATES , 1986 .

[21]  James D. Nichols,et al.  ESTIMATES OF MOVEMENT AND SITE FIDELITY USING MARK-RESIGHT DATA OF WINTERING CANADA GEESE' , 1991 .

[22]  C. Gardiner,et al.  CHRONIC UPPER RESPIRATORY TRACT DISEASE OF FREE-RANGING DESERT TORTOISES (XEROBATES AGASSIZII) , 1991, Journal of wildlife diseases.

[23]  Lori D. Wendland,et al.  Improved Enzyme-Linked Immunosorbent Assay To Reveal Mycoplasma agassizii Exposure: a Valuable Tool in the Management of Environmentally Sensitive Tortoise Populations , 2007, Clinical and Vaccine Immunology.

[24]  M. Oli,et al.  The Relative Importance of Life‐History Variables to Population Growth Rate in Mammals: Cole’s Prediction Revisited , 2003, The American Naturalist.

[25]  M. Duane.  Life in the Burrow: The Gopher Tortoise as a Keystone Species , 2007 .

[26]  Jim Hone,et al.  Estimating the force of infection; Mycobacterium bovis infection in feral ferrets Mustela furo in New Zealand , 2002 .

[27]  A. de Kruif,et al.  Patterns of Mycoplasma hyopneumoniae infections in Belgian farrow-to-finish pig herds with diverging disease-course. , 2002, Journal of veterinary medicine. B, Infectious diseases and veterinary public health.

[28]  E. McCoy,et al.  Declines of the gopher tortoise on protected lands , 2006 .

[29]  P. Klein,et al.  Green turtle fibropapillomatosis: challenges to assessing the role of environmental cofactors. , 1995, Environmental health perspectives.

[30]  David R. Anderson,et al.  Model selection and multimodel inference : a practical information-theoretic approach , 2003 .

[31]  M. Conroy,et al.  Analysis and Management of Animal Populations , 2002 .

[32]  Bradley P. Carlin,et al.  Bayesian measures of model complexity and fit , 2002 .

[33]  L. R. Finch,et al.  Mycoplasmas: molecular biology and pathogenesis. , 1992 .

[34]  P. Hosseini,et al.  Dynamics of a novel pathogen in an avian host: Mycoplasmal conjunctivitis in house finches. , 2005, Acta tropica.

[35]  William J. Browne,et al.  Bayesian and likelihood-based methods in multilevel modeling 1 A comparison of Bayesian and likelihood-based methods for fitting multilevel models , 2006 .

[36]  P. Klein,et al.  PATHOLOGY OF UPPER RESPIRATORY TRACT DISEASE OF GOPHER TORTOISES IN FLORIDA , 2000, Journal of wildlife diseases.

[37]  Peter J. Hudson,et al.  The ecology of wildlife diseases , 2002 .

[38]  P. Klein,et al.  Upper Respiratory Tract Disease in the Gopher Tortoise Is Caused by Mycoplasma agassizii , 1999, Journal of Clinical Microbiology.

[39]  M. Woodford.  INTERNATIONAL DISEASE IMPLICATIONS FOR WILDLIFE TRANSLOCATION , 1993 .

[40]  E. Jacobson.  CAUSES OF MORTALITY AND DISEASES IN TORTOISES , 1994 .

[41]  C. Rupprecht,et al.  Rabies in Endangered Ethiopian Wolves , 2004, Emerging infectious diseases.

[42]  F. R. Cagle.  A System of Marking Turtles for Future Identification , 1939 .

[43]  R. Dietz,et al.  Retrospective of the 1988 European seal epizootic , 1992 .

[44]  K. Berry,et al.  PATHOLOGY OF DISEASES IN WILD DESERT TORTOISES FROM CALIFORNIA , 1998, Journal of wildlife diseases.

[45]  M. Scott.  The Impact of Infection and Disease on Animal Populations: Implications for Conservation Biology , 1988 .

[46]  D. Briles,et al.  Resistance to mycoplasmal lung disease in mice is a complex genetic trait , 1996, Infection and immunity.

[47]  P. Klein,et al.  Taxonomic analysis of the tortoise mycoplasmas Mycoplasma agassizii and Mycoplasma testudinis by 16S rRNA gene sequence comparison. , 1995, International journal of systematic bacteriology.

[48]  Hal Caswell,et al.  ESTIMATING POPULATION PROJECTION MATRICES FROM MULTI-STAGE MARK-RECAPTURE DATA , 2002 .

[49]  K. Nagy,et al.  CLINICAL DISEASE AND LABORATORY ABNORMALITIES IN FREE-RANGING DESERT TORTOISES IN CALIFORNIA (1990–1995) , 2003, Journal of wildlife diseases.

[50]  R. Pech,et al.  A model of the dynamics and control of an outbreak of foot and mouth disease in feral pigs in Australia. , 1988 .

[51]  M. Spalding,et al.  DISEASE MONITORING OF FREE-RANGING AND RELEASED WILDLIFE , 1993 .

[52]  Evan G. Cooch,et al.  Mycoplasma gallisepticum infection dynamics in a house finch population: seasonal variation in survival, encounter and transmission rate , 2004 .

[53]  David B. Dunson,et al.  Bayesian Data Analysis , 2010 .

[54]  P. Klein,et al.  Detection of antibodies to a pathogenic mycoplasma in desert tortoises (Gopherus agassizii) with upper respiratory tract disease , 1993, Journal of clinical microbiology.

[55]  R. Speare,et al.  Epidemic Disease and the Catastrophic Decline of Australian Rain Forest Frogs , 1996 .

[56]  E. Williams,et al.  Disease and Endangered Species: The Black‐footed Ferret as a Recent Example , 1988, Conservation Biology.

[57]  Peter Kareiva,et al.  Modeling Population Viability for the Desert Tortoise in the Western Mojave Desert , 1994 .